|By Marketwired .||
|July 7, 2014 01:16 PM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 07/07/14 -- Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTCBB:FOIFF) announced today it has raised $200,200 via a non-brokered private placement of 715,000 Units at a price of $0.28 per Unit. Each Unit comprises of one common share and one common share purchase warrant. Each warrant allows the holder to purchase an additional common share at $0.50 cents during the 24 month period following the close of the private placement. The proceeds will be used for the Company's working capital and general corporate purposes. The common shares and any common shares issued from the exercise of the warrants will be subject to a hold period of 4 months from the closing date.
The Company now has 50,349,679 common shares outstanding.
About Arch Biopartners
Arch Biopartners is a portfolio based biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies.
For more information on the Company, please consult the other public documents filed on SEDAR at www.sedar.com.
The Company's website address is: www.archbiopartners.com.
All statements, other than statements of historical fact, in this news release are forward looking statements that involve various risks and uncertainties, including, without limitation, statements regarding the future plans and objectives of the Company. There can be no assurance that such statements will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.
The CNSX has not reviewed and does not accept responsibility for the adequacy of this release.
Jun. 2, 2015 01:45 AM EDT Reads: 1,608
Jun. 2, 2015 01:30 AM EDT Reads: 2,791
Jun. 2, 2015 01:00 AM EDT Reads: 3,702
Jun. 2, 2015 12:30 AM EDT Reads: 2,057
Jun. 2, 2015 12:15 AM EDT Reads: 2,344
Jun. 2, 2015 12:15 AM EDT Reads: 3,455
Jun. 2, 2015 12:00 AM EDT Reads: 655
Jun. 2, 2015 12:00 AM EDT Reads: 590
Jun. 1, 2015 11:15 PM EDT Reads: 4,136
Jun. 1, 2015 11:15 PM EDT Reads: 1,327
Jun. 1, 2015 11:00 PM EDT Reads: 4,437
Jun. 1, 2015 10:45 PM EDT Reads: 688
SYS-CON Events announced today that SUSE, a pioneer in open source software, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place June 9-11, 2015, at the Javits Center in New York City, NY. SUSE provides reliable, interoperable Linux, cloud infrastructure and storage solutions that give enterprises greater control and flexibility. More than 20 years of engineering excellence, exceptional service and an unrivaled partner ecosystem power the products and support that help ...
Jun. 1, 2015 10:30 PM EDT Reads: 1,077
The 5th International DevOps Summit, co-located with 17th International Cloud Expo – being held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the...
Jun. 1, 2015 10:15 PM EDT Reads: 4,222
Jun. 1, 2015 09:15 PM EDT Reads: 641